首页> 外文OA文献 >In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs
【2h】

In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs

机译:新型三唑衍生物KP-103的体外抗真菌活性及其对豚鼠实验性足癣和皮肤念珠菌病的治疗作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vitro activity of KP-103, a novel triazole derivative, against pathogenic fungi that cause dermatomycoses and its therapeutic efficacy against plantar tinea pedis and cutaneous candidiasis in guinea pigs were investigated. MICs were determined by a broth microdilution method with morpholinepropanesulfonic acid-buffered RPMI 1640 medium for Candida species and with Sabouraud dextrose broth for dermatophytes and by an agar dilution method with medium C for Malassezia furfur. KP-103 was the most active of all the drugs tested against Candida albicans (geometric mean [GM] MIC, 0.002 μg/ml), other Candida species including Candida parapsilosis and Candida glabrata (GM MICs, 0.0039 to 0.0442 μg/ml), and M. furfur (GM MIC, 0.025 μg/ml). KP-103 (1% solution) was highly effective as a treatment for guinea pigs with cutaneous candidiasis and achieved mycological eradication in 8 of the 10 infected animals, whereas none of the imidazoles tested (1% solutions) was effective in even reducing the levels of the infecting fungi. KP-103 was as active as clotrimazole and neticonazole but was less active than lanoconazole and butenafine against Trichophyton rubrum (MIC at which 80% of isolates are inhibited [MIC80], 0.125 μg/ml) and Trichophyton mentagrophytes (MIC80, 0.25 μg/ml). However, KP-103 (1% solution) exerted therapeutic efficacy superior to that of neticonazole and comparable to those of lanoconazole and butenafine, yielding negative cultures for all samples from guinea pigs with plantar tinea pedis tested. This suggests that KP-103 has better pharmacokinetic properties in skin tissue than the reference drugs. Because the in vitro activity of KP-103, unlike those of the reference drugs, against T. mentagrophytes was not affected by hair as a keratinic substance, its excellent therapeutic efficacy seems to be attributable to good retention of its antifungal activity in skin tissue, in addition to its potency.
机译:研究了新型三唑衍生物KP-103对引起皮肤癣菌的致病真菌的体外活性及其对豚鼠足底癣和皮肤念珠菌病的治疗功效。 MIC是通过肉汤微稀释法,用吗啉丙烷磺酸缓冲的RPMI 1640培养基(针对念珠菌)和Sabouraud右旋糖肉汤(对于皮肤癣菌)和琼脂稀释法(对于糠醛马拉色菌)进行测定的。 KP-103是所有针对白色念珠菌(几何平均[GM] MIC,0.002μg/ ml),其他念珠菌包括副念珠菌和光滑念珠菌(GM MIC,0.0039至0.0442μg/ ml)最有效的药物,和糠M分支杆菌(GM MIC,0.025μg/ ml)。 KP-103(1%溶液)对患有皮肤念珠菌病的豚鼠非常有效,并且在10只受感染的动物中有8个可以根除真菌,而测试的咪唑(1%溶液)都无法有效降低其水平感染真菌。 KP-103的活性与克霉唑和neticonazole相同,但对红毛癣菌(抑制80%分离株的MIC [MIC80],0.125μg/ ml)和毛癣菌(MIC80,0.25μg/ ml)的活性低于兰诺康唑和丁那芬)。但是,KP-103(1%溶液)的治疗效果优于neticonazole,可与lanoconazole和butenafine媲美,对豚鼠所有经足底测试的样品产生阴性培养物。这表明,KP-103在皮肤组织中的药代动力学特性优于参考药物。由于KP-103的体外活性不同于参比药物,因此对毛发癣菌的体外活性不受角蛋白类物质的影响,因此其优异的治疗功效似乎归因于其抗真菌活性在皮肤组织中的良好保留,除了其效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号